Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 9/20 | 0.48 |
| ▸ | CA2 | P00918 | 9/20 | 0.48 |
| ▸ | CA12 | O43570 | 6/20 | 0.48 |
| ▸ | CA9 | Q16790 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | STK17B | O94768 | 1/20 | 0.43 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6683821 | 0.93 | TDP1 (0.51) | TDP1MEN1KMT2AGAAMAOA | |
| SCHEMBL26770583 | 0.88 | TDP1 (0.47) | TDP1MEN1KMT2AGAAMAOA | |
| SCHEMBL14448301 | 0.87 | TDP1 (0.46) | TDP1MEN1KMT2AGAAMAOA | |
| SCHEMBL3903197 | 0.87 | TDP1 (0.46) | TDP1MEN1KMT2AGAAMAOA | |
| SCHEMBL27912515 | 0.86 | TDP1 (0.41) | TDP1MEN1KMT2AGAAMAOA | |
| SCHEMBL569251 | 0.85 | TDP1 (0.74) | TDP1MEN1KMT2AGAAMAOA | |
| SCHEMBL10062524 | 0.83 | CA1 (0.53) | TDP1MEN1KMT2AGAACA1 | |
| SCHEMBL15779526 | 0.82 | TDP1 (0.40) | TDP1MEN1KMT2AGAAMAOA | |
| SCHEMBL7210090 | 0.82 | TDP1 (0.76) | TDP1MEN1KMT2AGAAMAOA | |
| SCHEMBL1629518 | 0.82 | TDP1 (0.65) | TDP1MEN1KMT2AGAAMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066620-A1 | WATER-BORNE HYBRID VARNISH AND THE METHOD OF ITS PREPARATION | Vysoké ucení technické v Brne | 2025-02-27 | — | — | US | claimed |
| WO-2023116955-A1 | WATER-BORNE HYBRID VARNISH AND THE METHOD OF ITS PREPARATION | Centrum organické chemie s.r.o. (CZ) | 2023-06-29 | — | — | WO | claimed |
| US-20230201098-A1 | Oral Care Compositions | KENVUE BRANDS LLC | 2023-06-29 | — | — | US | claimed |
| EP-3997138-A1 | ACRYLIC POLYMER AND ADHESIVE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2022-05-18 | — | — | EP | claimed |
| US-20220133945-A1 | Acrylic Polymer and Adhesive Compositions | HENKEL AG & CO. KGAA (DE) | 2022-05-05 | — | — | US | claimed |
| WO-2021007584-A1 | ACRYLIC POLYMER AND ADHESIVE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2021-01-14 | — | — | WO | claimed |
| US-20200332061-A1 | NITRIC OXIDE-RELEASING HYPERBRANCHED COMPOUNDS AS ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2020-10-22 | — | — | US | claimed |
| EP-3720416-A1 | ORAL CARE COMPOSITION | Johnson & Johnson Consumer Inc. (US) | 2020-10-14 | — | — | EP | claimed |
| EP-3710514-A1 | NITRIC OXIDE-RELEASING HYPERBRANCHED COMPOUNDS AS ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO | The University of North Carolina at Chapel Hill (US) | 2020-09-23 | — | — | EP | claimed |
| US-20190175486-A1 | Oral Care Compositions | JOHNSON & JOHNSON CONSUMER INC. | 2019-06-13 | — | — | US | claimed |
| WO-2019112868-A1 | ORAL CARE COMPOSITION | JOHNSON & JOHNSON CONSUMER INC. (US) | 2019-06-13 | — | — | WO | claimed |
| EP-3075807-B1 | ADHESIVE COMPOSITION | LG CHEMICAL LTD (KR) | 2018-09-26 | — | — | EP | claimed |
| US-9834709-B2 | Pressure sensitive adhesive composition | LG CHEM, LTD. (KR) | 2017-12-05 | — | — | US | claimed |
| EP-3075807-A1 | ADHESIVE COMPOSITION | LG Chem, Ltd. (KR) | 2016-10-05 | — | — | EP | claimed |
| US-20160194532-A1 | PRESSURE SENSITIVE ADHESIVE COMPOSITION | LG CHEM, LTD. (KR) | 2016-07-07 | — | — | US | claimed |
| US-20260092166-A1 | A PLURALITY OF MICROCAPSULES AND USE THEREOF IN POLYMERS | CALYXIA SAS (FR) | 2026-04-02 | — | — | US | disclosed |
| EP-3759528-B1 | SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2026-03-04 | — | — | EP | disclosed |
| WO-1999043688-A1 | PHOTOACTIVATABLE NUCLEIC ACID DERIVATIVES | SURMODICS, INC. (US) | 1999-09-02 | — | — | WO | disclosed |
| WO-1999016907-A2 | REAGENT AND METHOD FOR ATTACHING TARGET MOLECULES TO A SURFACE | SURMODICS, INC. (US) | 1999-04-08 | — | — | WO | disclosed |
| US-5858653-A | Reagent and method for attaching target molecules to a surface | SURMODICS, INC. (US) | 1999-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092166-A1 | A PLURALITY OF MICROCAPSULES AND USE THEREOF IN POLYMERS | PHOSPHO1, DAGLA, SMCHD1 | TDP1 4040/4885MEN1 3790/4885KMT2A 4155/4885 |
| US-20230201098-A1 | Oral Care Compositions | VCL, MVD, ARG1 | TDP1 2255/4885MEN1 3222/4885KMT2A 3085/4885 |
| US-20200332061-A1 | NITRIC OXIDE-RELEASING HYPERBRANCHED COMPOUNDS AS ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO | NOS2, NOS1, NOS3 | TDP1 1021/4885MEN1 3920/4885KMT2A 2607/4885 |
| US-20190175486-A1 | Oral Care Compositions | VCL, MVD, ARG1 | TDP1 2255/4885MEN1 3222/4885KMT2A 3085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.